Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2.82% is 75% below its 2-year average of -1.62%, near the high end of its 2-year range (-28.25%–5.49%).
129.16% below its 12-month average of -1.23%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.90%.
OPERATING MARGIN
-2.82%
OPERATING MARGIN AVG TTM
-1.23%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-129.16%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Park Dental Partners, Inc. Common Stock
Market Cap
$92.33M
Operating Margin
-2.82%
TTM Avg
-1.23%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$90.32M
Operating Margin
-3270.86%
TTM Avg
-6391.41%
3Y Avg
-3195.70%
5Y Avg
-2130.47%
Market Cap
$89.78M
Operating Margin
0.00%
TTM Avg
-10.06%
3Y Avg
-113.57%
5Y Avg
-75.71%
Market Cap
$89.33M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.26M
Operating Margin
-37.64%
TTM Avg
-44.68%
3Y Avg
-118.22%
5Y Avg
-258.09%
Market Cap
$88.60M
Operating Margin
7.31%
TTM Avg
8.88%
3Y Avg
-4.43%
5Y Avg
-3.84%
Market Cap
$88.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$88.21M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $92.33M | -2.82% | -1.23% | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $90.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rallybio Corporation (RLYB)vs › | $90.32M | -3270.86% | -6391.41% | -3195.70% | -2130.47% |
| Equillium, Inc. (EQ)vs › | $89.78M | 0.00% | -10.06% | -113.57% | -75.71% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $89.26M | -37.64% | -44.68% | -118.22% | -258.09% |
| CareCloud, Inc. (CCLD)vs › | $88.60M | 7.31% | 8.88% | -4.43% | -3.84% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $88.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 12.60% | -0.11% | -11.38% | -8.86% |
| Korro Bio, Inc. (KRRO)vs › | $97.24M | -1366.43% | -2706.78% | -1353.39% | -914.67% |
Gross Margin
10.9%
Operating Margin
-2.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 1.90% |
| 2026-03-31 | -3.00% |
| 2025-12-31 | -13.45% |
| 2025-09-30 | 2.91% |
| 2025-06-30 | 5.49% |
| 2025-03-31 | 5.49% |
| 2024-12-31 | -28.25% |
| 2024-09-30 | 2.33% |
| 2024-06-30 | 5.21% |
| 2024-03-31 | 5.21% |
